ConductScience.org, home

Paper16770646

CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.

Vuilleumier N and 8 others. Eur J Clin Pharmacol, 2006. Cited by 119 papers, by iCite.

Cite this record

ConductScience Library. CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis. Papers, record 16770646. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16770646

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
2006
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
119
iCite
Relative citation ratio, by iCite
3.54
iCite
Revised in PubMed
2018-11-13
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vuilleumier NNicolas
2Rossier MFMichel F
3Chiappe AAlberto
4Degoumois FFlorence
5Dayer PPierre
6Mermillod BBernadette
7Nicod LLaurent
8Desmeules JJules
9Hochstrasser DDenis

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antitubercular AgentsMajor topic
Cytochrome P-450 CYP2E1Major topic
IsoniazidMajor topic
LiverMajor topic
Adolescent
Adult
Aged
Arylamine N-Acetyltransferase
Base Sequence
Chemical and Drug Induced Liver Injury
DNA Primers
Female
Gene Frequency
Genotype
Humans
Male
Middle Aged
Pharmacogenetics
Polymorphism, Restriction Fragment Length
Prospective Studies
Tuberculosis, Pulmonary

Source PubMed

Download CSV of topics

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19295061Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish population.Pharmacogenetics1997https://conductscience.org/library/papers/9295061PubMed
22304098Isoniazid toxicity presenting as seizures and metabolic acidosis.J Natl Med Assoc1990https://conductscience.org/library/papers/2304098PubMed
312172891Cytochrome P4502E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene.Int Arch Occup Environ Health2002https://conductscience.org/library/papers/12172891PubMed
43717759Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin.Am Rev Respir Dis1986https://conductscience.org/library/papers/3717759PubMed
59321764A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid.J Med Genet1997https://conductscience.org/library/papers/9321764PubMed
611131457Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions.J Hepatol2000https://conductscience.org/library/papers/11131457PubMed
77668286Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity.Am J Hum Genet1995https://conductscience.org/library/papers/7668286PubMed
87288121Risk factors for isoniazid (NIH)-induced liver dysfunction.J Clin Gastroenterol1981https://conductscience.org/library/papers/7288121PubMed
910881762Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.MMWR Recomm Rep2000https://conductscience.org/library/papers/10881762PubMed
1010889908Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis.Mol Pathol2000https://conductscience.org/library/papers/10889908PubMed
118354023Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans.Clin Pharmacol Ther1993https://conductscience.org/library/papers/8354023PubMed
1210208651Pitfalls in N-acetyltransferase 2 genotyping.Pharmacogenetics1999https://conductscience.org/library/papers/10208651PubMed
1310886461Cytochrome P450 2E1: its clinical and toxicological role.J Clin Pharm Ther2000https://conductscience.org/library/papers/10886461PubMed
149131488N-acetyltransferases: pharmacogenetics and clinical consequences of polymorphic drug metabolism.J Pharmacokinet Biopharm1996https://conductscience.org/library/papers/9131488PubMed
157485004Hepatotoxicity from isoniazid and rifampin in inner-city AIDS patients.Am J Gastroenterol1995https://conductscience.org/library/papers/7485004PubMed
16666111Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study.Am Rev Respir Dis1978https://conductscience.org/library/papers/666111PubMed
173997827Characterization of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid.J Biol Chem1985https://conductscience.org/library/papers/3997827PubMed
183957235Elevated serum aminotransferase induced by isoniazid in relation to isoniazid acetylator phenotype.Hepatology1986https://conductscience.org/library/papers/3957235PubMed
196367570Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis.Am Rev Respir Dis1984https://conductscience.org/library/papers/6367570PubMed
2010708202Acute isoniazid neurotoxicity during preventive therapy.Crit Care Med2000https://conductscience.org/library/papers/10708202PubMed

See all 41 referencesDownload CSV of references

Cited by63

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.

PMIDTitleJournalYearIn PapersSource
41104340Pharmacogenomics of antibiotic-induced hypersensitivity reactions: current evidence and implications in clinical practice.Front Pharmacol2025https://conductscience.org/library/papers/41104340PubMed
40538374Genetic polymorphisms and adverse reactions to antituberculosis therapy.Pharmacogenomics2025https://conductscience.org/library/papers/40538374PubMed
40488658Drug metabolizing enzymes and transporters, and their roles for the development of drug-induced liver injury.Expert Opin Drug Metab Toxicol2025https://conductscience.org/library/papers/40488658PubMed
39959342Clinical perspectives of isoniazid-induced liver injury.Liver Res2021https://conductscience.org/library/papers/39959342PubMed
39639188Pharmacogenomic insights into tuberculosis treatment shows the NAT2 genetic variants linked to hepatotoxicity risk: a systematic review and meta-analysis.BMC Genom Data2024https://conductscience.org/library/papers/39639188PubMed
38702595Influencing risk factors of voriconazole-induced liver injury in Uygur pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.BMC Pediatr2024https://conductscience.org/library/papers/38702595PubMed
38520539Formation of potentially toxic metabolites of drugs in reactions catalyzed by human drug-metabolizing enzymes.Arch Toxicol2024https://conductscience.org/library/papers/38520539PubMed
37786472Association of Cytochrome P450 2E1 and N-Acetyltransferase 2 Genotypes with Serum Isoniazid Level and Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Cross-Sectional Study.Iran J Med Sci2023https://conductscience.org/library/papers/37786472PubMed
37070117Hepatotoxicity induced by isoniazid in patients with latent tuberculosis infection: a meta-analysis.Gastroenterol Hepatol Bed Bench2023https://conductscience.org/library/papers/37070117PubMed
36562936Polymorphisms in drug metabolism genes as a risk factor for first-line anti-tuberculosis drug-induced liver injury.Mol Biol Rep2023https://conductscience.org/library/papers/36562936PubMed
36078027Hepatic, Extrahepatic and Extracellular Vesicle Cytochrome P450 2E1 in Alcohol and Acetaminophen-Mediated Adverse Interactions and Potential Treatment Options.Cells2022https://conductscience.org/library/papers/36078027PubMed
35751408NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patients.Mol Genet Genomic Med2022https://conductscience.org/library/papers/35751408PubMed
34539416Herb-Induced Liver Injury Related to Reynoutria multiflora (Thunb.) Moldenke: Risk Factors, Molecular and Mechanistic Specifics.Front Pharmacol2021https://conductscience.org/library/papers/34539416PubMed
34510815Allelic and genotypic frequencies of NAT2, CYP2E1, and AADAC genes in a cohort of Peruvian tuberculosis patients.Mol Genet Genomic Med2021https://conductscience.org/library/papers/34510815PubMed
33981901CYP2E1, GSTM1, and GSTT1 genetic polymorphisms and their associations with susceptibility to antituberculosis drug-induced liver injury in Thai tuberculosis patients.Heliyon2021https://conductscience.org/library/papers/33981901PubMed
33649521Development of a population pharmacokinetic model and Bayesian estimators for isoniazid in Tunisian tuberculosis patients.Pharmacogenomics J2021https://conductscience.org/library/papers/33649521PubMed
31375612Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis.BMJ Open2019https://conductscience.org/library/papers/31375612PubMed
30871660NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis.Int J Tuberc Lung Dis2019https://conductscience.org/library/papers/30871660PubMed
30090405Induction of protective autophagy against apoptosis in HepG2 cells by isoniazid independent of the p38 signaling pathway.Toxicol Res (Camb)2016https://conductscience.org/library/papers/30090405PubMed
30047605The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis.Br J Clin Pharmacol2018https://conductscience.org/library/papers/30047605PubMed

See all 63 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP2E11571PubTator's text mininghttps://conductscience.org/library/genes/1571NCBI Gene
NAT210PubTator's text mininghttps://conductscience.org/library/genes/10NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16770646

GET https://conductscience.org/api/papers/v1/16770646/references?page=2